About this event

  • Date and time Thu 10 Nov 2022 from 6:00pm to 8:00pm
  • Location Online
  • Organised by Ophthalmology

Join this meeting to examine new developments in glaucoma surgery and explore best practice for introduction and evaluation of innovative surgical treatments. The meeting will encompass advances in minimally invasive glaucoma surgery, bleb forming surgery, and methods to modify wound healing. Alternative methods of sustained release drug delivery will also be explored. Attendees will develop a better understanding of the options for glaucoma treatment and an improved appreciation for the factors determining treatment choices.

The purpose of this meeting is to explore best practice for introduction and evaluation of surgical innovations in ophthalmology and for attendees to be provided with an overview of new developments in glaucoma surgery. 

Benefits of attending: 

  • Develop your understanding of best practice regarding introduction of surgical innovations in ophthalmology. 
  • Enhance your understanding of the role of minimally invasive glaucoma surgery, including safety, efficacy, and patient selection. 
  • Refine your understanding of methods for modifying wound healing in glaucoma surgery. 
  • Understand potential future sustained release medical treatment options for glaucoma.

 

Follow us on: 
Facebook 
Instagram
LinkedIn
Twitter 
YouTube 

Key speakers

Professor Augusto Azuara-Blanco

Professor Augusto Azuara-Blanco

Clinical Professor of Ophthalmology, Queen's University Belfast

Speaker's biography

Professor Augusto Azuara-Blanco is a Clinical Professor of Ophthalmology and his work is mainly dedicated to people with glaucoma. With an academic career at the Centre of Public Health (Health Services Research Group) his work caters to investigating the effectiveness, safety and efficiency of new technologies for  eye diseases (e.g., treatments, diagnostic tests, models of eye care).  He has expertise in primary and secondary research methodology.He is the Chief Investigator of several publicly funded trials, including EAGLE, GATE, CHAMP, GRIP and ACE. He is the co-Chief Investigator of an ongoing trial on the In-home Tracking of glaucoma (i-TRAC) study.   He is a member of the research team and co-applicant of several publicly funded multicentre trials. Overall, he has received as CI or co-applicant over £15m of research funds from MRC, NIHR-EME, NIHR-HTA, Horizon 2020, and Wellcome Trust.Augusto has published over 250 peer-reviewed papers, over 20 book chapters, and edited three books.  His work has been cited over 8000 times and his current Scopus h-index is 45. Augusto is theCchair of the Scientific Committee of the European Glaucoma Society and a member of the Executive Management Committee of Evidence Synthesis Ireland. He chairs the UK NIHR CRN Clinical Study Group for glaucoma (from 2020) and is a Member of the NIHR-HTA prioritisation committee (from 2019). He was the Lead Editor of the European Glaucoma Society Guidelines (5th edition, 2020) and is the member of the Executive Commitee of the European Glaucoma Society (2016-2020). As Special Honours, he won the American Academy of Ophthalmology achievement award (2008), King James IV Professorship by the Royal College of Surgeons of Edinburgh (2020) and the American Academy of Ophthalmology Secretariat Award (2020).

Professor Jose M Martínez-de-la-Casa

Professor Jose M Martínez-de-la-Casa

Ophthalmologist, Hospital Clinico San Carlos

Speaker's biography

Professor Jose M Martínez de la Casa, Ph.D., is graduated in Medicine and Surgery from the Complutense University of Madrid. He is Head of the Glaucoma Department at Hospital Clinico San Carlos, Full Professor of Ophthalmology at the Universidad Complutense and Director of the Multidisciplinary Research group of the Universidad Complutense InnOftal. Dr. Martinez-de-la-Casa's specialty area is glaucoma, focused mainly on diagnosis and medical and surgical treatment He is the author of more than 150 publications in indexed journals and has collaborated in more than 20 ophthalmology textbooks. He has directed 28 Doctoral Theses. He is a member of the editorial board or a reviewer of 19 ophthalmology journals. He is currently Deputy Editor of the Archivos de la Sociedad Española de Oftalmología and Editor in Chief of the Revista Española de Glaucoma e Hipertensión Ocular.

Professor Ingeborg Stalmans

Professor Ingeborg Stalmans

Head, Glaucoma Clinic, University Hospitals UZ Leuven and Head, Research Group Ophthalmology, Catholic University KU Leuven

Speaker's biography

Professor Doctor Ingeborg Stalmans heads the Laboratory of Ophthalmology at the Catholic University of Leuven (KU Leuven) as well as the Glaucoma unit of the University Hospitals in Leuven (UZ Leuven). The current focus of her basic and clinical research work is medical glaucoma therapy, glaucoma surgery and retinal imaging as a biomarker for systemic diseases. She is a member of the Royal Academy of Medicine of Belgium, the President of the Belgian Glaucoma Society, the Vice-President of the European Glaucoma Society and serves in the Board of Governors of the World Glaucoma Society.

Mr Dan Lindfield

Mr Dan Lindfield

Consultant Ophthalmologist and Glaucoma Lead, Royal Surrey County Hospital and Training Programme Director for Ophthalmology, Health Education England: Kent, Surrey, Sussex

Speaker's biography

Mr Dan Lindfield is a Consultant Ophthalmologist and Glaucoma Director at Royal Surrey, Guildford. He also works for Health Education England as Director of the Ophthalmology Training Programme KSS. He trained in the south of England and London and undertook glaucoma fellowship training at St Thomas’ Hospital and Kings College Hospitals, London. He has won 16 national and international prizes, published 39 papers and has been an invited speaker across the UK and Europe. His main interests are complex cataract surgery, all aspects of glaucoma surgery and educational research. He won a prestigious HSJ National Patient Safety award in 2021 in addition to being named amongst the Top 100 Ophthalmologists in the world by The Ophthalmologist magazine 2018. In 2017 he was voted one of 50 “rising stars in world ophthalmology”, recognising his efforts and achievements in surgery, training, research and patient care.

Agenda

View the programme

Welcome and introduction

Mr Graham Duguid, President, Ophthalmology Section, Royal Society of Medicine and Mr Andrew Tatham, Consultant, Princess Alexandra Eye Pavilion

Evidence-based surgical innovation

Professor Augusto Azuara-Blanco, Clinical Professor of Ophthalmology, Queen's University Belfast

Build blebs better: Developments in bleb-forming surgery

Professor Jose M Martínez-de-la-Casa, Ophthalmologist, Hospital Clinico San Carlos

Dealing with healing in glaucoma surgery

Professor Ingeborg Stalmans, Head, Glaucoma Clinic, University Hospitals UZ Leuven and Head, Research Group Ophthalmology, Catholic University KU Leuven

MIGS: Enhancing physiological outflow

Mr Dan Lindfield, Consultant Ophthalmologist and Glaucoma Lead, Royal Surrey County Hospital and Training Programme Director for Ophthalmology, Health Education England: Kent, Surrey, Sussex

Innovations in sustained release medications

Mr Andrew Tatham

Panel discussion
Close of meeting

Location

Online





Registration for this virtual meeting will close on Thursday 10 November 2022 at 5pm.
You will receive the webinar link 1 hour before the meeting. Late registrations will not be accepted.
 
Webinar recordings will be available for registered delegates up to 60 days after the live webinar, via Zoom. The link will be sent 24 hours after the webinar takes place.
 
This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.